2.24
Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten
Has Ensysce Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewTop Performing Stocks - Newser
Why is Ensysce Biosciences Inc. stock attracting strong analyst attentionAccess exclusive market insights for free - jammulinksnews.com
Why Ensysce Biosciences Inc. stock attracts strong analyst attentionFree Top Growth Stock Recommendations - Newser
How volatile is Ensysce Biosciences Inc. stock compared to the marketStay ahead with advanced stock screening tools - jammulinksnews.com
Is Ensysce Biosciences Inc. a good long term investmentHigh-yield investments - PrintWeekIndia
What drives Ensysce Biosciences Inc. stock priceExponential wealth increase - Autocar Professional
Published on: 2025-07-25 08:23:29 - PrintWeekIndia
What analysts say about Ensysce Biosciences Inc. stockHigh-performance investment picks - jammulinksnews.com
When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com
Ensysce Biosciences Inc. Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com
Ensysce Biosciences initiates Phase 3 study of PF614 - TipRanks
FDA-Reviewed Phase 3 Trial Begins: Revolutionary Opioid Promises Pain Relief Without Abuse Risk - Stock Titan
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614A Next-Generation OpioidDesigned to Deliver Powerful Pain Relief and Reduce Abuse - The Globe and Mail
What makes Ensysce Biosciences Inc. stock price move sharplySolid Return Trade Selections - Newser
How Ensysce Biosciences Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser
NAVY(boat pilot token) Tokenomics ExplainedHigh Return Potential - Newser
Where are the Opportunities in (ENSC) - news.stocktradersdaily.com
Travere Therapeutics (NASDAQ:TVTX) and Ensysce Biosciences (NASDAQ:ENSC) Head to Head Comparison - Defense World
FDA-Designated Breakthrough Pain Drug Advances: New Solution to Opioid Overdose Crisis Shows Promise - Stock Titan
(ENSC) Investment Analysis - news.stocktradersdaily.com
Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World
Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan
(ENSC) On The My Stocks Page - news.stocktradersdaily.com
Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World
ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa
ensysce biosciences appoints baker tilly as new auditor - Investing.com
Ensysce Flat on Receiving Grant - Baystreet.ca
Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia
Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada
Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):